3 Health Insurance Stocks Poised To Beat On Earnings In Q3
Zacks Investment Research | Sep 27, 2019 08:52AM ET
The health insurance industry delivered a stellar operating performance in the first six months of 2019 with most players reporting higher top and the bottom-line numbers from the year-ago quarter as well as beating estimates on both counts.
An increase in membership and premiums was the main catalyst for top-line growth, leading to gains in the first two quarters of 2019. Medical cost management, better claims handling and cost-saving initiatives among others contributed to the bottom line.
Leading players including the likes of Humana, UnitedHealth Group Inc. (NYSE:UNH) , Cigna and Anthem also upped their respective earnings guidance for 2019. This reflects the companies’ continued optimism on the operating environment.
Nevertheless, year to date, the health insurance Earnings ESP Filter .
Cigna Corp. (NYSE:CI) has an Earnings ESP of +0.25% and a Zacks Rank #2. For the to-be-reported quarter, the company’s earnings are expected to grow 13.8%. The stock surpassed estimates in three of the last four quarters, the average positive surprise being 7.02%. You can see the complete list of today’s Zacks #1 Rank stocks here.
Anthem Inc. (NYSE:ANTM) has an Earnings ESP of +4.31% and a Zacks Rank of 2. For the quarter to be reported, the company’s earnings are estimated to jump 26.5%. The stock outpaced estimates over the trailing four quarters, the average being 4.57%.
Humana Inc. (NYSE:HUM) has an Earnings ESP of +1.77% and is Zacks #2 Ranked. For the impending quarterly results, earnings for the company are anticipated to inch up 0.22%. The stock trumped earnings estimates in all the preceding four quarters, the average being 7.79%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.